|
What is the impact of treatments received for MBC on the ability to perform activities of daily living, symptom burden, and productivity? |
|
|
Research Funding - Genentech (Inst); Takeda (Inst) |
|
|
|
Stock and Other Ownership Interests - Roche |
|
|
Employment - Genentech/Roche |
Stock and Other Ownership Interests - Genentech/Roche |
|
|
Research Funding - Celgene (Inst); Genentech (Inst) |
Travel, Accommodations, Expenses - GHI Pharma; Novartis |
|
|
|
Stock and Other Ownership Interests - Roche/Genentech |
Consulting or Advisory Role - Lilly |
Research Funding - University of Washington |
|
|
Research Funding - Celgene (Inst); Genentech (Inst) |
Travel, Accommodations, Expenses - Genomic Health |
|
|
No Relationships to Disclose |